Functional characterization of JMJD2A, a histone deacetylase- and retinoblastoma-binding protein - PubMed (original) (raw)
. 2005 Aug 5;280(31):28507-18.
doi: 10.1074/jbc.M413687200. Epub 2005 May 31.
Affiliations
- PMID: 15927959
- DOI: 10.1074/jbc.M413687200
Free article
Functional characterization of JMJD2A, a histone deacetylase- and retinoblastoma-binding protein
Steven G Gray et al. J Biol Chem. 2005.
Free article
Abstract
To effectively direct targeted repression, the class I histone deacetylases (HDACs) associate with many important regulatory proteins. In this paper we describe the molecular characterization of a member of the Jumonji domain 2 (JMJD2) family of proteins, and demonstrate its binding to both class I HDACs and the retinoblastoma protein (pRb). JMJD2 proteins are characterized by the presence of two leukemia-associated protein/plant homeodomain (LAP/PHD) zinc fingers, one JmjN, one JmjC (containing an internal retinoblastoma-binding protein 2 (RBBP2)-like sequence), and two Tudor domains. The first member of this group, JMJD2A, is widely expressed in human tissues and cell lines, and high endogenous expression of JMJD2A mRNA was found in several cell types, including human T-cell lymphotropic virus 1 (HTLV-1)-infected cell lines. JMJD2A and JMJD2B exhibit cell type-specific responses to the HDAC inhibitor trichostatin A. We show that the JMJD2A protein associates in vivo with pRb and class I HDACs, and mediates repression of E2F-regulated promoters. In HTLV-1 virus-infected cells, we find that JMJD2A binds to the viral Tax protein. Antibodies to JMJD2A recognize the native protein but also a half-sized protein fragment, the latter up-regulated in THP-1 cells during the G(2)/M phase of the cell cycle. The ability of JMJD2A to associate with pRb and HDACs and potentiate pRb-mediated repression of E2F-regulated promoters implies an important role for this protein in cell proliferation and oncogenesis.
Similar articles
- Identification and characterization of JMJD2 family genes in silico.
Katoh M, Katoh M. Katoh M, et al. Int J Oncol. 2004 Jun;24(6):1623-8. Int J Oncol. 2004. PMID: 15138608 - Diversity within the JMJD2 histone demethylase family.
Shin S, Janknecht R. Shin S, et al. Biochem Biophys Res Commun. 2007 Feb 23;353(4):973-7. doi: 10.1016/j.bbrc.2006.12.147. Epub 2006 Dec 27. Biochem Biophys Res Commun. 2007. PMID: 17207460 - JMJD2A is a novel N-CoR-interacting protein and is involved in repression of the human transcription factor achaete scute-like homologue 2 (ASCL2/Hash2).
Zhang D, Yoon HG, Wong J. Zhang D, et al. Mol Cell Biol. 2005 Aug;25(15):6404-14. doi: 10.1128/MCB.25.15.6404-6414.2005. Mol Cell Biol. 2005. PMID: 16024779 Free PMC article. - Histone acetylation and the cell-cycle in cancer.
Wang C, Fu M, Mani S, Wadler S, Senderowicz AM, Pestell RG. Wang C, et al. Front Biosci. 2001 Apr 1;6:D610-29. doi: 10.2741/1wang1. Front Biosci. 2001. PMID: 11282573 Review.
Cited by
- KDM4/JMJD2 histone demethylases: epigenetic regulators in cancer cells.
Berry WL, Janknecht R. Berry WL, et al. Cancer Res. 2013 May 15;73(10):2936-42. doi: 10.1158/0008-5472.CAN-12-4300. Epub 2013 May 3. Cancer Res. 2013. PMID: 23644528 Free PMC article. Review. - Readers, writers, and erasers: chromatin as the whiteboard of heart disease.
Gillette TG, Hill JA. Gillette TG, et al. Circ Res. 2015 Mar 27;116(7):1245-53. doi: 10.1161/CIRCRESAHA.116.303630. Circ Res. 2015. PMID: 25814685 Free PMC article. Review. - Noncanonical NF-κB pathway controls the production of type I interferons in antiviral innate immunity.
Jin J, Hu H, Li HS, Yu J, Xiao Y, Brittain GC, Zou Q, Cheng X, Mallette FA, Watowich SS, Sun SC. Jin J, et al. Immunity. 2014 Mar 20;40(3):342-54. doi: 10.1016/j.immuni.2014.02.006. Immunity. 2014. PMID: 24656046 Free PMC article. - Small molecule KDM4s inhibitors as anti-cancer agents.
Lin H, Li Q, Li Q, Zhu J, Gu K, Jiang X, Hu Q, Feng F, Qu W, Chen Y, Sun H. Lin H, et al. J Enzyme Inhib Med Chem. 2018 Dec;33(1):777-793. doi: 10.1080/14756366.2018.1455676. J Enzyme Inhib Med Chem. 2018. PMID: 29651880 Free PMC article. - Effects of siRNA-mediated knockdown of jumonji domain containing 2A on proliferation, migration and invasion of the human breast cancer cell line MCF-7.
Li BX, Luo CL, Li H, Yang P, Zhang MC, Xu HM, Xu HF, Shen YW, Xue AM, Zhao ZQ. Li BX, et al. Exp Ther Med. 2012 Oct;4(4):755-761. doi: 10.3892/etm.2012.662. Epub 2012 Aug 13. Exp Ther Med. 2012. PMID: 23170139 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials